
Company Info
Year Established2012
Ticker
RVMD
Exchange
NASDAQ
Contacts
Mark A. Goldsmith, M.D., Ph.D.Chair, President & CEO
Jeff Cislini, J.D.
General Counsel
Margaret (Peg) Horn, J.D.
COO
Daniel Simon
CBO
Jack Anders
CFO
Steve Kelsey, M.D.
President, R&D
Company Description
Revolution Medicines, formerly Warp Drive Bio, is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
